Insider · CIK 0001690773

Dable Habib J

Reports to the SEC for 10 companies · BOSTON, MA

sec.gov

Transactions

Companies

Filings

CIK

0001690773

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-18	PEPGPepGen Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+34K sh	—	—	34,000
2026-06-09	RLAYRelay Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+32.9K sh	—	—	32,947
2026-04-23	DAWNDay One Biopharmaceuticals, Inc. · Stock Option (right to buy Common Stock)D Disposition to Issuer	Director	DDisposition to Issuer	−32.3K sh	—	—	0
2026-04-23	DAWNDay One Biopharmaceuticals, Inc. · Stock Option (right to buy Common Stock)D Disposition to Issuer	Director	DDisposition to Issuer	−22.5K sh	—	—	0
2026-04-23	DAWNDay One Biopharmaceuticals, Inc. · Stock Option (right to buy Common Stock)D Disposition to Issuer	Director	DDisposition to Issuer	−66.7K sh	—	—	0
2026-04-23	DAWNDay One Biopharmaceuticals, Inc. · Restricted Stock Unit (RSU)D Disposition to Issuer	Director	DDisposition to Issuer	−15K sh	—	—	0
2026-04-16	TYRATyra Biosciences, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+44.4K sh	—	—	44,400
2026-02-05	SGPSpyGlass Pharma, Inc. · Stock Option (right to buy)A Award	Director	AAward	+27.4K sh	—	—	27,400
2025-11-06	DAWNDay One Biopharmaceuticals, Inc. · Stock Option (right to buy Common Stock)A Award	Director	AAward	+66.7K sh	—	—	66,660
2025-11-06	DAWNDay One Biopharmaceuticals, Inc. · Stock Option (right to buy Common Stock)D Disposition to Issuer	Director	DDisposition to Issuer	−66.7K sh	—	—	0
2025-11-06	DAWNDay One Biopharmaceuticals, Inc. · Stock Option (right to buy Common Stock)A Award	Director	AAward	+32.3K sh	—	—	32,335
2025-11-06	DAWNDay One Biopharmaceuticals, Inc. · Stock Option (right to buy Common Stock)D Disposition to Issuer	Director	DDisposition to Issuer	−32.3K sh	—	—	0
2025-11-04	RLAYRelay Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+208K sh	—	—	207,931
2025-07-17	Blueprint Medicines CorpStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−7,950 sh	—	—	0
2025-07-17	Blueprint Medicines CorpD Disposition to Issuer	Director	DDisposition to Issuer	−3,902 sh	—	—	8,742
2025-07-17	Blueprint Medicines CorpStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−5,300 sh	—	—	0
2025-07-17	Blueprint Medicines CorpU Disposition from Tender	Director	UDisposition from Tender	−8,742 sh	—	—	0
2025-07-17	Blueprint Medicines CorpStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−4,570 sh	—	—	0
2025-06-18	Blueprint Medicines CorpA Award	Director	AAward	+3,902 sh	$128.12	+$500K	12,644
2025-06-04	PEPGPepGen Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+16K sh	—	—	16,000
2025-06-02	DAWNDay One Biopharmaceuticals, Inc. · Restricted Stock Unit (RSU)A Award	Director	AAward	+15K sh	—	—	15,000
2025-06-02	DAWNDay One Biopharmaceuticals, Inc. · Stock Option (right to buy Common Stock)A Award	Director	AAward	+22.5K sh	—	—	22,500
2024-06-20	PEPGPepGen Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+13K sh	—	—	13,000
2024-06-12	Blueprint Medicines CorpA Award	Director	AAward	+2,242 sh	—	—	8,742
2024-06-12	Blueprint Medicines CorpStock Option (Right to Buy)A Award	Director	AAward	+4,570 sh	—	—	4,570
2024-06-05	JBIOJade Biosciences, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+12.5K sh	—	—	12,500
2024-05-23	DAWNDay One Biopharmaceuticals, Inc. · Stock Option (right to buy Common Stock)A Award	Director	AAward	+32.3K sh	—	—	32,335
2024-03-04	JBIOJade Biosciences, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+1,531 sh	$16.37	+$25.1K	1,531
2024-01-17	DAWNDay One Biopharmaceuticals, Inc. · Stock Option (right to buy Common Stock)A Award	Director	AAward	+66.7K sh	—	—	66,660
2024-01-02	JBIOJade Biosciences, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+2,964 sh	$13.49	+$40K	2,964
2023-07-10	JBIOJade Biosciences, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+25K sh	—	—	25,000
2023-06-22	PEPGPepGen Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+9,000 sh	—	—	9,000
2023-06-21	Blueprint Medicines CorpA Award	Director	AAward	+2,600 sh	—	—	6,500
2023-06-21	Blueprint Medicines CorpStock Option (Right to Buy)A Award	Director	AAward	+5,300 sh	—	—	5,300
2023-03-02	ALBIREO PHARMA, INC.Stock Options (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−16K sh	—	—	0
2022-10-03	PEPGPepGen Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+22.7K sh	—	—	22,686
2022-08-08	ALBIREO PHARMA, INC.Stock Options (Right to buy)A Award	Director	AAward	+16K sh	—	—	16,000
2022-06-23	Blueprint Medicines CorpStock Option (Right to Buy)A Award	Director	AAward	+7,950 sh	—	—	7,950
2022-06-23	Blueprint Medicines CorpA Award	Director	AAward	+3,900 sh	—	—	3,900
2021-11-19	ACCELERON PHARMA INCU Disposition from Tender	Director, CEO and President	UDisposition from Tender	−98.5K sh	—	—	0
2021-11-19	ACCELERON PHARMA INCOption to Purchase Common StockD Disposition to Issuer	Director, CEO and President	DDisposition to Issuer	−106K sh	—	—	0
2021-11-19	ACCELERON PHARMA INCOption to Purchase Common StockD Disposition to Issuer	Director, CEO and President	DDisposition to Issuer	−250K sh	—	—	0
2021-11-19	ACCELERON PHARMA INCOption to Purchase Common StockD Disposition to Issuer	Director, CEO and President	DDisposition to Issuer	−84.7K sh	—	—	0
2021-11-19	ACCELERON PHARMA INCOption to Purchase Common StockD Disposition to Issuer	Director, CEO and President	DDisposition to Issuer	−109K sh	—	—	0
2021-11-19	ACCELERON PHARMA INCOption to Purchase Common StockD Disposition to Issuer	Director, CEO and President	DDisposition to Issuer	−64.4K sh	—	—	0
2021-07-02	ACCELERON PHARMA INCS Sale	Director, CEO and President	SSale	−29.1K sh	$126.69	−$3.69M	111,496
2021-07-02	ACCELERON PHARMA INCOption to Purchase Common StockM Exercise/Conversion	Director, CEO and President	MExercise/Conversion	−42.2K sh	—	—	250,000
2021-07-02	ACCELERON PHARMA INCS Sale	Director, CEO and President	SSale	−1,588 sh	$128.21	−$204K	98,450
2021-07-02	ACCELERON PHARMA INCS Sale	Director, CEO and President	SSale	−11.5K sh	$127.51	−$1.46M	100,038
2021-07-02	ACCELERON PHARMA INCM Exercise/Conversion	Director, CEO and President	MExercise/Conversion	+42.2K sh	$35.04	+$1.48M	140,636

Recent filings

Accepted (ET)
Jun 224
Dable Habib J0001835597-26-000030
SEC(opens sec.gov)
Jun 104
Dable Habib J0001193125-26-265911
SEC(opens sec.gov)
Apr 234
Dable Habib J0001690773-26-000005
SEC(opens sec.gov)
Apr 204
Dable Habib J0001193125-26-164090
SEC(opens sec.gov)
Feb 94
Dable Habib J0001690773-26-000004
SEC(opens sec.gov)
Nov 74
Dable Habib J0001690773-25-000006
SEC(opens sec.gov)
Nov 64
Dable Habib J0001193125-25-269769
SEC(opens sec.gov)
Jul 214
Dable Habib J0001104659-25-069395
SEC(opens sec.gov)
Jun 244
Dable Habib J0001415889-25-018073
SEC(opens sec.gov)
Jun 64
Dable Habib J0001127602-25-016928
SEC(opens sec.gov)

Companies

Address

C/O PEPGEN INC. 321 HARRISON AVE 8TH FLOOR

BOSTON, MA, 02118